[1] 赵丹,王小兵,常青云,等.初治与复发性卵巢上皮癌组织中BRCA1、ERCC1、TUBB3、PRR13基因mRNA表达变化[J].癌症进展,2011,9(5):573-576.
[2] 刘梦娜,谢静燕,赵树立.雌激素受体在卵巢癌研究中的进展[J].东南大学学报(医学版),2014,33(2):215-218.
[3] 李玉娟,赵树立,谢静燕.外泌体在卵巢癌中的研究进展[J].东南大学学报(医学版),2017,36(2):256-259.
[4] 雷磊,王艳丽,梁静,等.卵巢上皮癌差异表达microRNAs的筛选研究[J].现代肿瘤医学,2013,21(2):398-402.
[5] SKIRNISDOTTIR I,SEIDAL T.Association of p21,p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer[J].Cancer Genomics Proteomics,2013,10(1):27-34.
[6] LEE C K,SIMES R J,BROWN C,et al.A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer[J].Ann Oncol,2013,24(4):937-943.
[7] 付清茹,齐红岩,荣安娜.晚期卵巢上皮癌新辅助化疗的研究进展[J].医学综述,2017,23(5):891-895.
[8] YIN M,LI C,LI X,et al.Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages Ⅲ and IV epithelial ovarian cancer[J].J Sur Oncol,2011,104(1):29-36.
[9] WILLIAMSON E A,WOLF I,O'KELLY J,et al.BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)[J].Oncogene,2006,25(9):1391-1399.
[10] HABASHY H O,POWE D G,RAKHA E A,et al.Forkhead-box A1(FOXA1) expression in breast cancer and its prognostic significance[J].Eur J Cancer,2008,44(11):1541-1551.
[11] HAUPTMANN S,DU BOIS A,MEINHOLD-HERLEIN I,et al.[Histological grading of epithelial ovarian cancer.Review and recommendation] [J].Pathologe,2014,35(5):497-503.
[12] TORRE L A,TRABERT B,DESANTIS C E,et al.Ovarian cancer statistics,2018[J].CA Cancer J Clin,2018,68(4):284-296.
[13] KAESTNER K H,KNOCHEL W,MARTINEZ D E.Unified nomenclature for the winged helix/forkhead transcription factors[J].Genes Dev,2000,14(2):142-146.
[14] WANG K,GUAN C,FANG C,et al.Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer[J].Oncol Lett,2018,15(4):4457-4462.
[15] KATOH M,IGARASHI M,FUKUDA H,et al.Cancer genetics and genomics of human FOX family genes[J].Cancer Lett,2013,328(2):198-206.
[16] LIN L,MILLER C T,CONTRERAS J I,et al.The hepatocyte nuclear factor 3 alpha gene,HNF3alpha (FOXA1),on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas[J].Cancer Res,2002,62(18):5273-5279.
[17] LI Z,TUTEJA G,SCHUG J,et al.Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer[J].Cell,2012,148(1-2):72-83.
[18] SONG Y,WASHINGTON M K,CRAWFORD H C.Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer[J].Cancer Res,2010,70(5):2115-2125.
[19] BASSERES D S,D'ALO F,YEAP B Y,et al.Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing[J].Lung Cancer,2012,77(1):31-37.
[20] BADVE S,TURBIN D,THORAT M A,et al.FOXA1 expression in breast cancer——correlation with luminal subtype A and survival[J].Clin Cancer Res,2007,13(15 Pt 1):4415-4421. |